FR2411608A1 - Procede pour extraire le facteur anti-hemophilique viii du sang ou du plasma sanguin - Google Patents

Procede pour extraire le facteur anti-hemophilique viii du sang ou du plasma sanguin

Info

Publication number
FR2411608A1
FR2411608A1 FR7835543A FR7835543A FR2411608A1 FR 2411608 A1 FR2411608 A1 FR 2411608A1 FR 7835543 A FR7835543 A FR 7835543A FR 7835543 A FR7835543 A FR 7835543A FR 2411608 A1 FR2411608 A1 FR 2411608A1
Authority
FR
France
Prior art keywords
blood
factor viii
blood plasma
hemophilic factor
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7835543A
Other languages
English (en)
Other versions
FR2411608B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOLAN GAIL
Original Assignee
DOLAN GAIL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOLAN GAIL filed Critical DOLAN GAIL
Publication of FR2411608A1 publication Critical patent/FR2411608A1/fr
Application granted granted Critical
Publication of FR2411608B1 publication Critical patent/FR2411608B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'INVENTION CONCERNE UN PROCEDE POUR EXTRAIRE LE FACTEUR ANTI-HEMOPHILIQUE VIII DU SANG OU DU PLASMA SANGUIN. CE PROCEDE CONSISTE A RECUEILLIR DU SANG ENTIER OU DU PLASMA SANGUIN OU DES FRACTIONS DE PLASMA SANGUIN D'UN DONNEUR, DIRECTEMENT DANS UN ANTICOAGULANT QUI N'ALTERE PAS LES CONCENTRATIONS PHYSIOLOGIQUES DU CALCIUM OU D'AUTRES IONS DANS LE PLASMA DU SANG ENTIER OU LES FRACTIONS DE PLASMA SANGUIN, PUIS A EXTRAIRE LE FACTEUR ANTI-HEMOPHILIQUE VIII CONFORMEMENT A DES TECHNIQUES CLASSIQUES DE SEPARATION. LA DEFICIENCE ABSOLUE OU RELATIVE DU FACTEUR ANTI-HEMOPHILIQUE VIII EST LA CAUSE DE L'HEMOPHILIEA CLASSIQUE.
FR7835543A 1977-12-19 1978-12-18 Procede pour extraire le facteur anti-hemophilique viii du sang ou du plasma sanguin Granted FR2411608A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA293,393A CA1074698A (fr) 1977-12-19 1977-12-19 Methode pour augmenter la production de facteur antihemophilique viii dans le sang et le plasma

Publications (2)

Publication Number Publication Date
FR2411608A1 true FR2411608A1 (fr) 1979-07-13
FR2411608B1 FR2411608B1 (fr) 1983-05-20

Family

ID=4110324

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7835543A Granted FR2411608A1 (fr) 1977-12-19 1978-12-18 Procede pour extraire le facteur anti-hemophilique viii du sang ou du plasma sanguin

Country Status (8)

Country Link
US (1) US4203891A (fr)
JP (1) JPS596288B2 (fr)
AT (1) AT365453B (fr)
CA (1) CA1074698A (fr)
DE (1) DE2854381A1 (fr)
FR (1) FR2411608A1 (fr)
GB (1) GB1577504A (fr)
SE (1) SE448275B (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022052A2 (fr) * 1979-06-19 1981-01-07 David Amrani Procédé pour la séparation et l'isolement de la fraction AHF (facteur antihémophilique), la fraction fibronectine et la fraction Von Willebrand's ristocétine cofacteur à partir du plasma sanguin
EP0077119A2 (fr) * 1981-10-01 1983-04-20 Gail Ann Rock Collection de facteur VIII antihémophilique
EP0098256A2 (fr) * 1982-06-28 1984-01-11 Monsanto Company Production du facteur de coagulation du sang VIII:C
EP0238701A1 (fr) * 1986-03-27 1987-09-30 Octapharma AG Procédé de production d'un facteur anti-hémophilique hautement purifié

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
SE448945B (sv) * 1979-12-20 1987-03-30 Blombaeck E G B Forfarande for rening och /eller koncentrering av faktor viii-komplexet
EP0033582B1 (fr) * 1980-01-18 1984-04-11 The Canadian Red Cross Society Procédé d'obtention du facteur huit
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
US4405612A (en) * 1980-05-23 1983-09-20 Riker Laboratories, Inc. Heparin web compositions
JPS57500982A (fr) * 1980-05-23 1982-06-03
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
US4359463A (en) * 1980-11-26 1982-11-16 Rock Gail A Stabilization of Factor VIII activity in whole blood or blood plasma
GB2096174B (en) * 1981-04-08 1984-05-10 Atomic Energy Authority Uk Blood fractionation
US4479799A (en) * 1981-05-21 1984-10-30 Riker Laboratories, Inc. Hypodermic syringe containing microfibers of an amorphous heparin salt
EP0081482A1 (fr) * 1981-06-18 1983-06-22 E. G. Birger Blombäck Procede de purification et de concentration du complexe de facteur viii
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
DE3247563A1 (de) * 1982-12-22 1984-06-28 Rovema Verpackungsmaschinen GmbH, 6301 Fernwald Vorrichtung zur zufuehrung von faltschachtelzuschnitten zu einer kartoniermaschine
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
HUT40311A (en) * 1983-06-03 1986-12-28 Kiskunhalasi Aag Process for producing protein concentrates, blood-curd and nutriments from blood and its elements
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
JPS6154597A (ja) * 1984-08-25 1986-03-18 松下電工株式会社 半導体式熱感知器
US4928603A (en) * 1984-09-07 1990-05-29 The Trustees Of Columbia University In The City Of New York Method of preparing a cryoprecipitated suspension and use thereof
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
DE4230513C1 (de) * 1992-09-11 1994-03-31 Fresenius Ag Vorrichtung zur Entfernung von Aluminiumionen aus Blut und Lösung zur Verwendung in der Vorrichtung
DE19634313A1 (de) * 1996-08-24 1998-02-26 Behringwerke Ag Methode zur Stabilisierung von Plättchen
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
SE1050124A1 (sv) * 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2184898A1 (fr) * 1972-05-17 1973-12-28 Baxter Laboratories Inc

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2847348A (en) * 1954-05-27 1958-08-12 Ortho Pharma Corp Plasma fractionation and product therefrom
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
US3548052A (en) * 1964-10-27 1970-12-15 Canada Packers Ltd Heparin compositions and methods of using same
US3453194A (en) * 1966-08-03 1969-07-01 Dow Corning Anticoagulant surfaces produced by radiation grafting heparin to a silicone substrate
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
GB1399824A (en) * 1971-08-16 1975-07-02 Mar Pha Etu Expl Marques Heparin esters
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4137223A (en) * 1977-05-16 1979-01-30 Edward Shanbrom, Inc. Method of preserving blood plasma II

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2184898A1 (fr) * 1972-05-17 1973-12-28 Baxter Laboratories Inc

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1971 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022052A2 (fr) * 1979-06-19 1981-01-07 David Amrani Procédé pour la séparation et l'isolement de la fraction AHF (facteur antihémophilique), la fraction fibronectine et la fraction Von Willebrand's ristocétine cofacteur à partir du plasma sanguin
EP0022052A3 (fr) * 1979-06-19 1981-11-11 David Amrani Procédé pour la séparation et l'isolement de la fraction AHF (facteur antihémophilique), la fraction fibronectine et la fraction Von Willebrand's ristocétine cofacteur à partir du plasma sanguin
EP0077119A2 (fr) * 1981-10-01 1983-04-20 Gail Ann Rock Collection de facteur VIII antihémophilique
EP0077119A3 (fr) * 1981-10-01 1985-01-16 Gail Ann Rock Collection de facteur VIII antihémophilique
EP0098256A2 (fr) * 1982-06-28 1984-01-11 Monsanto Company Production du facteur de coagulation du sang VIII:C
EP0098256A3 (en) * 1982-06-28 1985-10-23 Monsanto Company Production of blood coagulation factor viii:c
EP0238701A1 (fr) * 1986-03-27 1987-09-30 Octapharma AG Procédé de production d'un facteur anti-hémophilique hautement purifié

Also Published As

Publication number Publication date
DE2854381A1 (de) 1979-06-21
ATA902478A (de) 1981-06-15
CA1074698A (fr) 1980-04-01
SE7812967L (sv) 1979-06-20
US4203891A (en) 1980-05-20
GB1577504A (en) 1980-10-22
JPS5498308A (en) 1979-08-03
JPS596288B2 (ja) 1984-02-10
SE448275B (sv) 1987-02-09
AT365453B (de) 1982-01-25
FR2411608B1 (fr) 1983-05-20

Similar Documents

Publication Publication Date Title
FR2411608A1 (fr) Procede pour extraire le facteur anti-hemophilique viii du sang ou du plasma sanguin
FR2296373A1 (fr) Procede d'extraction d'une proteine de sources vegetales
EP0022052A3 (fr) Procédé pour la séparation et l'isolement de la fraction AHF (facteur antihémophilique), la fraction fibronectine et la fraction Von Willebrand's ristocétine cofacteur à partir du plasma sanguin
DE3381283D1 (de) Vorrichtung zur serumabscheidung aus blut.
DE3884352T2 (de) Pervaporationsverfahren zur Trennung von Alkoholen von Äthern.
IT7821110A0 (it) Provetta di separazione per la separazione mediante centrifugazione.
ATE318625T1 (de) Sammelsystem für thrombozyten
DE3586832D1 (de) Vorrichtung zum abtrennen von blutplasma-eiweiss.
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
MA19533A1 (fr) Procede pour l'extraction d'ions de metaux lourds de solutions aqueuses
EP0077119A2 (fr) Collection de facteur VIII antihémophilique
BE872224A (fr) Procede de production d'une margarine a faible valeur calorique contenant un concentre proteique de lait ecreme
DE3776819D1 (de) Vorrichtung fuer die herstellung von filterzigaretten.
IT1142030B (it) Metodo per abbassare il livello del colesterolo nel sangue
FR2540119B1 (fr) Procede de fractionnement des phosphatides
DE3783941T2 (de) Verfahren zur herstellung von fluessigen triarylthiophosphat-mischungen.
DE69932151D1 (de) Verfahren und vorrichtung zum transformieren von plasma
IT7922675A0 (it) Metodo per ridurre la concentrazione di lipidi nel sangue.
KR900009444A (ko) 염기성 수용액으로부터 구리를 분리하는 방법
NL7702068A (nl) Werkwijze ter bereiding van zuivere alkalifosfaat- oplossingen uit langs de natte weg verkregen fos- forzuren.
EP0033582A2 (fr) Procédé d'obtention du facteur huit
ES544174A0 (es) Un procedimiento continuo de etapas multiples para separar fracciones proteinicas de plasma sanguineo
JPS54126716A (en) Separation of platelet
CA1115637A (fr) Methode pour l'obtention d'un facteur viii de purete intermediaire
JPS5777623A (en) Method for preparing blood preparation using activated earth

Legal Events

Date Code Title Description
ST Notification of lapse